Soto, N E <br/><br/>
Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization.  [electronic resource] 

 -  Infection control and hospital epidemiology  May 1999 
 - 351-3 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0899-823X 
<br/><br/><label>Standard No.: </label>10.1086/501633  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Bacterial Agents--therapeutic use<br/>Bacitracin--therapeutic use<br/>Carrier State--drug therapy<br/>Cross Infection--prevention & control<br/>Female<br/>Humans<br/>Infection Control--methods<br/>Infectious Disease Transmission, Professional-to-Patient--prevention & control<br/>Male<br/>Mupirocin--therapeutic use<br/>Nasal Mucosa--microbiology<br/>Prospective Studies<br/>Single-Blind Method<br/>Staphylococcal Infections--prevention & control<br/>Staphylococcus aureus--drug effects<br/>Treatment Outcome